Brief: ESSA Pharma Amends Agreement with XenoTherapeutics
Sept 24 (Reuters) - ESSA Pharma Inc EPIX.O: ESSA PHARMA INC. AMENDS AGREEMENT WITH XENOTHERAPEUTICS ESSA PHARMA INC - SHAREHOLDERS TO RECEIVE $0.12 PER SHARE ESSA PHARMA INC - CVR REPRESENTS RIGHT TO RECEIVE UP TO $0.14 PER SHARE ESSA PHARMA INC - TO APPLY TO SUPREME COURT TO AMEND INTERIM ORDER ESSA PHARMA INC - ADJOURNS SPECIAL MEETING TO OCTOBER 3, 2025 Source text: ID:nCNW5cfYQa Further company coverage: EPIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ESSA Pharma
See all newsBrief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: ESSA Pharma Provides Update On Its Application To The Supreme Court Of British Columbia For Amended Interim Order
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics